HERCEPTIN TRASTUZUMAB Trademark

Trademark Overview

On Friday, May 26, 2006, a trademark application was filed for HERCEPTIN TRASTUZUMAB with the United States Patent and Trademark Office. The USPTO has given the HERCEPTIN TRASTUZUMAB trademark a serial number of 78894574. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, February 28, 2018. This trademark is owned by Genentech, Inc.. The HERCEPTIN TRASTUZUMAB trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing information on the subject of medical conditions and therapies via a global computer network
herceptin trastuzumab

General Information

Serial Number78894574
Word MarkHERCEPTIN TRASTUZUMAB
Filing DateFriday, May 26, 2006
Status800 - REGISTERED AND RENEWED
Status DateWednesday, February 28, 2018
Registration Number3478204
Registration DateTuesday, July 29, 2008
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 27, 2007

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding information on the subject of medical conditions and therapies via a global computer network

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 2, 2006
Primary Code044
First Use Anywhere DateTuesday, February 28, 2006
First Use In Commerce DateTuesday, February 28, 2006

Trademark Owner History

Party NameGenentech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990

Trademark Events

Event DateEvent Description
Saturday, June 3, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Friday, September 22, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 23, 2006ASSIGNED TO EXAMINER
Tuesday, November 14, 2006EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, June 2, 2006NEW APPLICATION ENTERED
Tuesday, November 14, 2006EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, December 20, 2006ASSIGNED TO LIE
Friday, January 12, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 7, 2007NOTICE OF PUBLICATION
Tuesday, February 27, 2007PUBLISHED FOR OPPOSITION
Tuesday, May 22, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 19, 2007SOU TEAS EXTENSION RECEIVED
Monday, November 19, 2007SOU EXTENSION 1 FILED
Monday, November 19, 2007SOU EXTENSION 1 GRANTED
Tuesday, May 13, 2008SOU TEAS EXTENSION RECEIVED
Tuesday, November 21, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 21, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 20, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 13, 2008SOU EXTENSION 2 FILED
Tuesday, May 13, 2008SOU EXTENSION 2 GRANTED
Monday, June 23, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 25, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, July 29, 2008REGISTERED-PRINCIPAL REGISTER
Thursday, June 19, 2014TEAS SECTION 8 & 15 RECEIVED
Thursday, May 29, 2008TEAS STATEMENT OF USE RECEIVED
Thursday, May 29, 2008USE AMENDMENT FILED
Wednesday, June 4, 2008STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 28, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, February 28, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, February 28, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, July 8, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 8, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 8, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Monday, February 5, 2018TEAS SECTION 8 & 9 RECEIVED
Friday, February 23, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 28, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

trastuzumab herceptin global computer network therapies conditions information subject medical providing